Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.

Awad G, Ng-Mak D, Rajagopalan K, Hsu J, Pikalov A, Loebel A.

BMC Psychiatry. 2016 Jun 1;16:176. doi: 10.1186/s12888-016-0879-5.

2.

Attitudes toward psychotropic medications among patients with chronic psychiatric disorders and their family caregivers.

Grover S, Chakrabarti S, Sharma A, Tyagi S.

J Neurosci Rural Pract. 2014 Oct;5(4):374-83. doi: 10.4103/0976-3147.139989.

3.

The relationship between insight and subjective experience in schizophrenia.

Kako Y, Ito K, Hashimoto N, Toyoshima K, Shimizu Y, Mitsui N, Fujii Y, Tanaka T, Kusumi I.

Neuropsychiatr Dis Treat. 2014 Jul 29;10:1415-22. doi: 10.2147/NDT.S66121. eCollection 2014.

4.

Attitudes toward Medication and Reasons for Non-Compliance in Patients with Schizophrenia.

Chandra IS, Kumar KL, Reddy MP, Reddy CM.

Indian J Psychol Med. 2014 Jul;36(3):294-8. doi: 10.4103/0253-7176.135383.

5.

Attitudes towards antipsychotics among patients with schizophrenia on first- or second-generation medications.

Karthik MS, Warikoo N, Chakrabarti S, Grover S, Kulhara P.

Indian J Psychol Med. 2014 Jul;36(3):288-93. doi: 10.4103/0253-7176.135382.

6.

A cross-sectional study on perception of stigma by Chinese schizophrenia patients.

Ren Z, Wang H, Feng B, Gu C, Ma Y, Chen H, Li B, Liu L.

Neuropsychiatr Dis Treat. 2014 Mar 26;10:535-40. doi: 10.2147/NDT.S54115. eCollection 2014. Erratum in: Neuropsychiatr Dis Treat. 2014;10:1333. Retraction in: Neuropsychiatr Dis Treat. 2015;11:895.

7.

Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.

Awad G, Hassan M, Loebel A, Hsu J, Pikalov A, Rajagopalan K.

BMC Psychiatry. 2014 Feb 23;14:53. doi: 10.1186/1471-244X-14-53.

8.

Medication adherence in schizophrenia.

Acosta FJ, Hernández JL, Pereira J, Herrera J, Rodríguez CJ.

World J Psychiatry. 2012 Oct 22;2(5):74-82. doi: 10.5498/wjp.v2.i5.74. Review.

9.

Neurocognition, insight and medication nonadherence in schizophrenia: a structural equation modeling approach.

Boyer L, Cermolacce M, Dassa D, Fernandez J, Boucekine M, Richieri R, Vaillant F, Dumas R, Auquier P, Lancon C.

PLoS One. 2012;7(10):e47655. doi: 10.1371/journal.pone.0047655. Epub 2012 Oct 29.

10.

Short-term clinical stability and lack of insight are associated with a negative attitude towards antipsychotic treatment at discharge in patients with schizophrenia and bipolar disorder.

Medina E, Salvà J, Ampudia R, Maurino J, Larumbe J.

Patient Prefer Adherence. 2012;6:623-9. doi: 10.2147/PPA.S34345. Epub 2012 Aug 29.

11.

Relationships between stereotyped beliefs about mental illness, discrimination experiences, and distressed mood over 1 year among persons with schizophrenia enrolled in rehabilitation.

Lysaker PH, Tunze C, Yanos PT, Roe D, Ringer J, Rand K.

Soc Psychiatry Psychiatr Epidemiol. 2012 Jun;47(6):849-55. doi: 10.1007/s00127-011-0396-2. Epub 2011 May 21.

12.

Reasons for illicit drug use in people with schizophrenia: Qualitative study.

Asher CJ, Gask L.

BMC Psychiatry. 2010 Nov 22;10:94. doi: 10.1186/1471-244X-10-94.

13.

Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study.

Bitter I, Treuer T, Dilbaz N, Oyffe I, Ciorabai EM, Gonzalez SL, Ruschel S, Salburg J, Dyachkova Y.

World J Biol Psychiatry. 2010 Oct;11(7):894-903. doi: 10.3109/15622975.2010.505663.

14.

Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophrenia.

Liu-Seifert H, Adams DH, Ascher-Svanum H, Faries DE, Kinon BJ.

Patient Prefer Adherence. 2007 Dec 20;1:9-17.

15.

Attitudes toward medication and the clinical variables in schizophrenia: Structural equation models.

Rossi A, Pacifico R, Stratta P.

Patient Prefer Adherence. 2009 Nov 3;3:305-9.

16.

Attitudes toward taking medication among outpatients with schizophrenia: cross-national comparison between Tokyo and Beijing.

Kuroda N, Sun S, Lin CK, Morita N, Kashiwase H, Yang F, Nakatani Y.

Environ Health Prev Med. 2008 Sep;13(5):288-95. doi: 10.1007/s12199-008-0043-z. Epub 2008 Aug 12.

17.

Patients' health literacy in psychotic disorders.

Saba G, Mékaoui L, Leboyer M, Schürhoff F.

Neuropsychiatr Dis Treat. 2007 Aug;3(4):511-7.

18.

Medication adherence in schizophrenia: exploring patients', carers' and professionals' views.

Kikkert MJ, Schene AH, Koeter MW, Robson D, Born A, Helm H, Nose M, Goss C, Thornicroft G, Gray RJ.

Schizophr Bull. 2006 Oct;32(4):786-94. Epub 2006 Aug 3.

19.

Defining and assessing adherence to oral antipsychotics: a review of the literature.

Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL.

Schizophr Bull. 2006 Oct;32(4):724-42. Epub 2006 May 17. Review.

Items per page

Supplemental Content

Write to the Help Desk